MiNK Therapeutics, Inc.
INKT
$11.71
-$0.48-3.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.85M | 1.85M | 1.27M | 808.90K | 1.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 193.90K | -- | -- | -62.70K | 180.90K |
| Total Operating Expenses | 3.18M | 3.69M | 2.53M | 4.37M | 1.88M |
| Operating Income | -3.18M | -3.69M | -2.53M | -4.37M | -1.88M |
| Income Before Tax | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M |
| EBIT | -3.18M | -3.69M | -2.53M | -4.37M | -1.88M |
| EBITDA | -3.14M | -3.64M | -2.48M | -4.26M | -1.82M |
| EPS Basic | -0.65 | -1.06 | -0.70 | -0.62 | -0.46 |
| Normalized Basic EPS | -0.41 | -0.61 | -0.41 | -0.65 | -0.29 |
| EPS Diluted | -0.65 | -1.06 | -0.70 | -1.25 | -0.46 |
| Normalized Diluted EPS | -0.41 | -0.61 | -0.41 | -0.65 | -0.29 |
| Average Basic Shares Outstanding | 4.44M | 3.98M | 3.97M | 3.96M | 3.95M |
| Average Diluted Shares Outstanding | 4.44M | 3.98M | 3.97M | 3.96M | 3.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |